201 related articles for article (PubMed ID: 29078759)
1. Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency.
Törmänen S; Pörsti I; Lakkisto P; Tikkanen I; Niemelä O; Paavonen T; Mustonen J; Eräranta A
BMC Nephrol; 2017 Oct; 18(1):323. PubMed ID: 29078759
[TBL] [Abstract][Full Text] [Related]
2. Unfavorable Reduction in the Ratio of Endothelin B to A Receptors in Experimental 5/6 Nephrectomy and Adenine Models of Chronic Renal Insufficiency.
Törmänen S; Lakkisto P; Eräranta A; Kööbi P; Tikkanen I; Niemelä O; Mustonen J; Pörsti I
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023824
[TBL] [Abstract][Full Text] [Related]
3. Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.
Dhaun N; Yuzugulen J; Kimmitt RA; Wood EG; Chariyavilaskul P; MacIntyre IM; Goddard J; Webb DJ; Corder R
J Am Heart Assoc; 2015 Mar; 4(3):e001624. PubMed ID: 25801761
[TBL] [Abstract][Full Text] [Related]
4. A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro.
Kawata T; Tokunaga S; Murai M; Masuda N; Haruyama W; Shoukei Y; Hisada Y; Yanagida T; Miyazaki H; Wada M; Akizawa T; Fukagawa M
PLoS One; 2018; 13(4):e0195316. PubMed ID: 29614098
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
[TBL] [Abstract][Full Text] [Related]
6. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
[TBL] [Abstract][Full Text] [Related]
7. Quercetin Treatment Improves Renal Function and Protects the Kidney in a Rat Model of Adenine-Induced Chronic Kidney Disease.
Yang H; Song Y; Liang YN; Li R
Med Sci Monit; 2018 Jul; 24():4760-4766. PubMed ID: 29987270
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet attenuates the renal endothelial-to-mesenchymal transition in rats with adenine-induced renal failure.
Wu M; Tang RN; Liu H; Xu M; Pan MM; Liu BC
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F138-46. PubMed ID: 24154694
[TBL] [Abstract][Full Text] [Related]
9. Adenine-induced chronic kidney and cardiovascular damage in rats.
Diwan V; Mistry A; Gobe G; Brown L
J Pharmacol Toxicol Methods; 2013; 68(2):197-207. PubMed ID: 23732959
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM).
Wetmore JB; Gurevich K; Sprague S; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1031-40. PubMed ID: 25904755
[TBL] [Abstract][Full Text] [Related]
11. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
[TBL] [Abstract][Full Text] [Related]
12. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
Muller ME; Forni Ogna V; Maillard M; Stoudmann C; Zweiacker C; Anex C; Wuerzner G; Burnier M; Bonny O
Pflugers Arch; 2015 Dec; 467(12):2413-21. PubMed ID: 26089029
[TBL] [Abstract][Full Text] [Related]
13. Dietary phosphate binding and loading alter kidney angiotensin-converting enzyme mRNA and protein content in 5/6 nephrectomized rats.
Eräranta A; Riutta A; Fan M; Koskela J; Tikkanen I; Lakkisto P; Niemelä O; Parkkinen J; Mustonen J; Pörsti I
Am J Nephrol; 2012; 35(5):401-8. PubMed ID: 22517117
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
Dhaun N; MacIntyre IM; Bellamy CO; Kluth DC
Am J Kidney Dis; 2009 Oct; 54(4):726-31. PubMed ID: 19376621
[TBL] [Abstract][Full Text] [Related]
15. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
[TBL] [Abstract][Full Text] [Related]
16. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
17. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
[TBL] [Abstract][Full Text] [Related]
18. Renal cellular hypoxia in adenine-induced chronic kidney disease.
Fong D; Ullah MM; Lal JG; Abdelkader A; Ow CP; Hilliard LM; Ricardo SD; Kelly DJ; Evans RG
Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):896-905. PubMed ID: 27385644
[TBL] [Abstract][Full Text] [Related]
19. Influence of treatment with gum acacia on renal vascular responses in a rat model of chronic kidney disease.
Al Suleimani YM; Al Za'abi M; Ramkumar A; Al Mahruqi AS; Tageldin MH; Nemmar A; Ali BH
Eur Rev Med Pharmacol Sci; 2015; 19(3):498-506. PubMed ID: 25720725
[TBL] [Abstract][Full Text] [Related]
20. [The use of Cinacalcet in chronic kidney disease: a case report].
Russo R; Argentino G; Maresca ID; Sannino G; Memoli A; Memoli B
G Ital Nefrol; 2015; 32(4):. PubMed ID: 26252263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
